STUDY | ACCR. GOAL |
R E G |
O P E N |
ARM | TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
---|---|---|---|---|---|---|---|---|---|---|
S1703-Met Breast, STM-monitoring v Usual Care | 1320 | 1 | Y | 0 Screening | 429 | 95 | 50 | 29 | 7 | 1 |
429 | 95 | 50 | 29 | 7 | 1 | |||||
2 | Y | 1 Control (Usual Care) | 142 | 29 | 21 | 12 | 5 | 2 | ||
2 Intervention (STMDDM) | 139 | 27 | 15 | 8 | 2 | 0 | ||||
281 | 56 | 36 | 20 | 7 | 2 | |||||
S1912CD-CREDIT, Fin Counseling to reduce Fin Hardship | 536 | 1 | Y | 1 Financial Navigation | 41 | 28 | 18 | 8 | 2 | 0 |
2 Control | 42 | 27 | 19 | 9 | 3 | 1 | ||||
83 | 55 | 37 | 17 | 5 | 1 | |||||
S2108CD-Genomic Tumor Board vs Usual Practice | 1182 | 1 | Y | 1 Usual Practice | 196 | 196 | 194 | 142 | 44 | 4 |
2 EGTB Intervention | 161 | 161 | 157 | 104 | 41 | 8 | ||||
357 | 357 | 351 | 246 | 85 | 12 | |||||
A231602C-Blood Cancer, Assess Financial Difficulty | 1 | T | 4 | 0 | 0 | 0 | 0 | 0 | ||
4 | 0 | 0 | 0 | 0 | 0 | |||||
ACCL16N1-Guideline Consistent Treatment AYA ALL | 1 | T | 54 | 0 | 0 | 0 | 0 | 0 | ||
54 | 0 | 0 | 0 | 0 | 0 | |||||